Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(Nonaqueous Titration) | min. 95.0 % |
Melting point | 217.0 to 221.0 °C |
NMR | confirm to structure |
Axitinib
(E)-N-Methyl-2-[[3-[2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl]thio]benzamide; N-Methyl-2-[[3-[(1E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
Purity / Analysis Method | >95.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C22H18N4OS = 386.47 |
Storage Temperature | 0-10°C |
CAS RN | 319460-85-0 |
Unit | Price |
50 mg | 4500 |
100 mg | 7250 |
1 g | 15750 |
Note | •Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
---|